Fairfax India Holdings Corporation
FFXDFOTCFinancial Services● Active
$18.18
+$0.03(+0.14%)
Market Cap$1.9B
P/E Ratio—
52W High$20.49
52W Low$15.46
Fairfax India Holdings Corporation（FFXDF）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · FFXDF · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.44B | ($0.03B) | $0.38B | $0.19B | $0.49B |
| Depreciation & Amort. | $0.00B | $0.00B | $0.00B | ($0.00B) | ($0.00B) |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | $0.00B | ($0.11B) | $0.00B | $0.00B | $0.01B |
| Net Cash from Operations | ($0.04B) | ($0.10B) | $0.07B | $0.15B | $0.06B |
| Investing Activities | |||||
| Capital Expenditure | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Purchases of Investments | $0.00B | ($0.34B) | $0.00B | ($0.18B) | ($0.31B) |
| Sales of Investments | $0.00B | $0.37B | $0.39B | $0.43B | $0.41B |
| Net Cash from Investing | $0.00B | $0.00B | $0.00B | $0.25B | $0.10B |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.01B) | ($0.01B) | ($0.04B) | ($0.04B) | ($0.13B) |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.00B | $0.00B | ($0.05B) |
| Net Cash from Financing | ($0.01B) | ($0.01B) | ($0.04B) | ($0.04B) | ($0.05B) |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.04B) | ($0.10B) | $0.07B | $0.15B | $0.06B |
| FCF Margin %(computed) | -36.11% | -298.55% | 11.09% | 72.56% | 11.27% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Fairfax India Holdings Corporation
关于Fairfax India Holdings Corporation（FFXDF）现金流量表
Fairfax India Holdings Corporation 2025财年经营活动现金流($0.04B)，自由现金流($0.04B)（FCF利润率-36.11%），资本支出$0.00B。
常见问题
FFXDF · 4 问Fairfax India Holdings Corporation 2025财年自由现金流($0.04B)，同比up61.2%。
FFXDF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10